Abstract
Microbes have been good to us. They have given us thousands of valuable products with novel structures and activities. In nature, they only produce tiny amounts of these secondary metabolic products as a matter of survival. Thus, these metabolites are not overproduced in nature, but they must be overproduced in the pharmaceutical industry. Genetic manipulations are used in industry to obtain strains that produce hundreds or thousands of times more than that produced by the originally isolated strain. These strain improvement programs traditionally employ mutagenesis followed by screening or selection; this is known as ‘brute-force’ technology. Today, they are supplemented by modern strategic technologies developed via advances in molecular biology, recombinant DNA technology, and genetics. The progress in strain improvement has increased fermentation productivity and decreased costs tremendously. These genetic programs also serve other goals such as the elimination of undesirable products or analogs, discovery of new antibiotics, and deciphering of biosynthetic pathways.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Protoplast Fusion
- Penicillium Chrysogenum
- Strain Improvement
- Genome Shuffling
- Combinatorial Biosynthesis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Parekh S (2000) Strain improvement. In: J Lederberg (ed): Encyclopedia of microbiology, vol. 4, 2nd ed. Academic Press, San Diego, 428–443
Vinci VA, Byng G (1999) Strain improvement by nonrecombinant methods. In: AL Demain, JE Davies (eds): Manual of industrial microbiology and biotechnology, 2nd ed. ASM Press, Washington, DC, 103–113
Parekh S, Vinci VA, Strobel RJ (2000) Improvement of microbial strains and fermentation processes. Appl Microbiol Biotechnol 54: 287–301
Simpson IN, Caten CE (1979) Induced quantitative variation for penicillin titre in clonal populations of Aspergillus nidulans. J Gen Microbiol 110: 1–12
Baltz RH (1986) Mutagenesis in Streptomyces. In: AL Demain, NA Solomon (eds): Manual of industrial microbiology and biotechnology. ASM, Washington, DC, 184–190
Baltz RH (1995) Gene expression in recombinant Streptomyces. In: A Smith (ed): Gene expression in recombinant microorganisms. Marcel Dekker, New York, 309–381
Baltz RH (1998) Genetic manipulation of antibiotic producing Streptomyces. Trends Microbiol 6: 76–83
Baltz RH (1999) Mutagenesis. In: MC Flickinger, SW Drew (eds): Encyclopedia ofbioprocessing technology: fermentation, biocatalysis, and separation. Wiley, New York, 1819–1822
Keller U (1983) Highly efficient mutagenesis of Claviceps purpurea by using protoplasts. Appl Environ Microbiol 46: 580–584
Takebe H, Imai S, Ogawa H, Satoh A, Tanaka H (1989) Breeding of bialaphos producing strains from a biochemical engineering viewpoint. J Ferm Bioeng 67: 226–232
Kim KS, Cho NY, Pai HS, Ryu DDY (1983) Mutagenesis of Micromonospora rosaria by using protoplasts and mycelial fragments. Appl Environ Microbiol 46: 689–693
Kurzatkowski W, Kurylowicz W, Solecka J, Penyige A (1986) Improvement of Streptomyces strains by the regeneration of protoplasts. In: G Szabo, S Biro, M Goodfellow (eds): Biological, biochemical and biomedical aspects of actinomycetes. Part A. Academiai Kiado, Budapest, 289–292
Strohl WR (2001) Biochemical engineering of natural product biosynthesis pathways. Metab Eng 3: 4–14
Hersbach GJM, van der Beck CP, van Dijck PWM(1984) The penicillins: properties, biosynthesis, and fermentation. In: EJ Vandamme (ed): Biotechnology of industrial antibiotics. Marcel Dekker, New York, 45–140
Smith DJ, Bull JH, Edwards J, Turner G (1989) Amplification of the isopenicillin N synthetase gene in a strain of Penicillium chrysogenum producing high levels of penicillin. Mol Gen Genet 216: 492–497
Barredo JL, Diez B, Alvarez E, Martin JF (1989) Large amplification of a 35-kb DNA fragment carrying two penicillin biosynthetic genes in high penicillin producing strains of P. chrysogenum. Curr Genet 16: 453–459
Smith DJ, Burnham MKR, Bull JH, Hodgson JE, Ward JM, Browne P, Brown J, Barton B, Earl AJ, Turner G (1990) β-Lactam antibiotic biosynthesis genes have been conserved in clusters in prokaryotes and eukaryotes. EMBO J 9: 741–747
Fierro F, Barredo JL, Diez B, Gutierrez S, Fernandez FJ, Martin JF (1995) The penicillin gene cluster is amplified in tandem repeats linked by conserved hexanucleotide sequences. Proc Natl Acad Sci USA 92: 6200–6204
Podojil M, Blumauerova M, Culik K, Vanek Z (1984) The tetracycyclines: properties, biosynthesis and fermentation. In: EJ Vandamme (ed): Biotechnology of industrial antibiotics. Marcel Dekker, New York, 259–279
Demain AL, Elander RP (1999) The β-lactam antibiotics: past, present, and future. Ant v Leeuwenhoek 75: 5–19
Chen W-Q, Yu ZN, Zheng Y-H (2004) Expression of Vitreoscilla hemoglobin gene in Streptomyces fradiae and its effect on cell growth and synthesis of tylosin. Chin J Antibiot 29: 516–520
Liu C-M (1982) Microbial aspects of polyether antibiotics: activity, production and biosynthesis. In: JW Westley (ed): Polyether antibiotics. Naturally occurring acid ionophores. Vol. 1. Biology. Marcel Dekker, New York, 43–102
Blumauerova M, Pokorny V, Stastna J, Hostalek Z, Vanek Z (1978) Developmental mutants of Streptomyces coeruleorubidis, a producer of anthracyclines: isolation and preliminary characterization. Folia Microbiol 23: 177–182
Blumaerova M, Podojil M, Gauze G., Maksikmova TS, Panos J, Vanek Z (1980) Spontaneous variability of Streptomyces glomeratus, a producer of anthracycline antibiotics beromycins. Folia Microbiol 25: 207–212
Blumaerova M, Podojil M, Gauze GF, Maksikmova TS, Panos J, Vanek Z (1980) Effect of cultivation conditions on the activity of the beromycin producer Streptomyces glomeratus 3980 and its spontaneous variants. Folia Microbiol 25: 213–218
Lee JC, Park HR, Park DJ, Son KH, Yoon KH, Kim YB, Kim CJ (2003) Production of teicoplanin by a mutant of Actinoplanes teicomyceticus. Biotechnol Lett 25: 537–540
Haavik HI, Froyshov O (1982) On the role of L-leucine in the control of bacitracin formation by Bacillus licheniformis. In: H Kleinkauf, H von Doehren (eds): Peptide antibiotics: biosynthesis and functions. Walter de Gruyter, Berlin, 155–159
Godfrey O (1973) Isolation of regulatory mutants of the aspartic and pyruvic acid families and their effect on antibiotic production in Streptomyces lipmanii. Antimicrob Agents Chemother 4: 73–79
Lee SH, Lee KJ (1995) Threonine dehydratases in different strains of Streptomyces fradiae. J Biotechnol 43: 95–102
Polsinelli M, Albertini A, Cassani G, Ciferri O (1965) Relation of biochemical mutations to actinomycin synthesis in Streptomyces antibioticus. J Gen Microbiol 39: 239–246
Saburova TP, Lapchinskaya OA, Sinyagina OP, Trutneva EM, Lvova NA (1977) Auxotrophic mutants in selection of Actinomyces coeruleorubidus, an organism producing rubomycin. Antibiotiki 22: 1095–1100
Dulaney EL, Dulaney DD (1967) Mutant populations of Streptomyces viridifaciens. Trans NY Acad Sci II 29: 782–799
Unowsky J, Hoppe DC (1978) Increased production of the antibiotic aurodox (X-5108) by aurodox-resistant mutants. J Antibiot 31: 662–666
Mendelovitz S, Aharonowitz Y (1983) β-Lactam antibiotic production by Streptomyces clavuligerus mutants impaired in regulation of aspartokinase. J Gen Microbiol 129: 2063–2069
Smith A (1987) Enzyme regulation of desferrioxamine biosynthesis: a basis for a rational approach to process development. In: M Alacevic, D Hranueli, Z Toman (eds): Fifth International Symposium on the Genetics of Industrial Microorganisms 1986. Pliva, Zagreb, 513–527
Pospisil S, Kopecky J, Prikrylova V, Spizek J (1999) Overproduction of 2-ketoisovalerate and monensin production by regulatory mutants of Streptomyces cinnamonensis resistant to 2-ketobutyrate and amino acids. FEMS Microbiol Lett 172: 197–204
Wang MR, Ding H, Hu YJ (1996) The action of arginine and valine in the biosynthesis of teicoplanin. Chin J Antibiot 21 (Suppl): 77–80
Jin ZH, Wang MR, Cen PL (2002a) Production of teichoplanin by valine-analogue resistant mutant strains of Actinoplanes teichomyceticus. Appl Microbiol Biotechnol 58: 63–66
Barrios-Gonzalez J, Montenegro E, Martin JF (1993) Penicillin production by mutants resistant to phenylacetic acid. J Ferm Bioeng 7: 455–458
Jin ZH, Lin JP, Xu ZN, Cen PL (2002b) Improvement of industry-applied rifamycin Bproducing strain, Amycolatopsis mediterranei, by rational screening. J Gen Appl Microbiol 48: 329–334
Elander RP, Aoki H (1982) β-Lactam producing microorganisms — their biology and fermentation behavior. In: RB Morin, M Gorman (eds): Chemistry and biology of β-lactam antibiotics, vol. 3. Academic Press, New York, 83–153
Higashide E (1984) The macrolides; properties, biosynthesis, and fermentation. In: EJ Vandamme (ed): Biotechnology of industrial antibiotics. Marcel Dekker, New York, 451–509
Gravius B, Glocker D, Pigac J, Pandza K, Hranueli D, Cullum J (1994) The 387 kb linear plasmid pPZG101 of Streptomyces rimosus and its interactions with the chromosome. Microbiology 140: 2271–2277
Crameri R, Davies JE (1986) Increased production of aminoglycosides associated with amplified antibiotic resistance genes. J Antibiot 39: 128–135
Hosoya Y, Okamoto S, Muramatsu H, Ochi K (1998) Acquisition of certain streptomycin resistant (str) mutations enhances antibiotic production in bacteria. Antimicrob Agents Chemother 42: 2041–2047
Hesketh A, Ochi K (1997) A novel method for improving Streptomyces coelicolor A3(2) for production of actinorhodin by introduction of rpsL (encoding ribosomal protein S12) mutations conferring resistance to streptomycin. J Antibiot 50: 532–535
Okamoto S, Lezhava A, Hosaka T, Okamoto-Hosoya Y, Ochi K (2003) Enhanced expression of S-adenosylmethionine synthetase causes overproduction of actinorhodin in Streptomyces coelicolor A3(2). J Bacteriol 185: 601–609
Okamoto-Hosoya Y, Sato T, Ochi K (2000) Resistance to paromomycin is conferred by rpsL mutations, accompanied by an enhanced antibiotic production in Streptomyces coelicolor A3(2). J Antibiot 53: 1424–1427
Hu H, Ochi K (2001) Novel approach for improving the production of antibiotic-producing strains by inducing combined resistant mutations. Appl Environ Microbiol 67: 1885–1892
Tamehiro N, Hosaka T, Xu J, Hu H, Otake N, Ochi K (2003) Innovative approach for improvement of an antibiotic-overproducing industrial strain of Strepromyces albus. Appl Environ Microbiol 69: 6412–6417
Chang LT, McGrory EL, Elander RP (1980) Penicillin production by glucose-derepressed mutants of Penicillium chrysogenum. J Indust Microbiol 6: 165–169
Colombo AL, Crespi-Pevellino N, Grein A, Minghetti A, Spalla CJ (1981) Metabolic and genetic aspects of the relationship between growth and tetracycline production in Streptomyces aureofaciens. Biotechnol Lett 3: 71–76
Martin JF, Naharro G, Liras P, Villanueva JR (1979) Isolation of mutants deregulated in phosphate control of candicidin biosynthesis. J Antibiot 32: 600–606
Elander RP (1969) Applications of microbial genetics to industrial fermentations. In: D Perlman (ed): Fermentation Advances. Academic Press, New York, 89–114
Katagiri I (1954) Study on chlortetracycline. Improvement of chlortetracycline-producing strain by several kinds of methods. J Antibiot 7: 45–52
Bannerjee AB, Bose SK (1964) A rapid method for isolating mutants of Bacillus subtilis producing increased or decreased amounts of the antibiotic, mycobacillin. J Appl Bacteriol 27: 93–95
Ditchburn P, Giddings B, MacDonald KD (1974) Rapid screening for the isolation of mutants of Aspergillus nidulans with increased penicillin yields. J Appl Bacteriol 37: 515–523
Ichikawa T, Date M, Ishikura T, Ozaki A (1971) Improvement of kasugamycin-producing strain by agar piece method and the prototroph method. Folia Microbiol 16: 218–224
Chang LT, Elander RP (1979) Rational selection for improved cephalosporin C productivity in strains of Acremonium chrysogenum. Devel Indust Microbiol 20: 367–379
Gesheva V (1994) Isolation of spontaneous Streptomyces hygroscopicus 111–81 phosphate-deregulated mutants hyperproducing its antibiotic complex. Biotechnol Lett 16: 443–448
Nakatsukasa WM, Mabe JA (1978) Galactose induced colonial dissociation in Streptomyces aureofaciens. J Antibiot 31: 805–808
Kitano K, Nozaki Y, Imada A (1985) Selective accumulation of unsulfated carbapenem antibiotics by sulfate transport-negative mutants of Streptomyces griseus subsp. cryophilus C-19393. Agric Biol Chem 49: 677–684
Omura S, Ikeda H, Tanaka H (1991) Selective production of specific components of avermectins in Streptomyces avermitilis. J Antibiot 44: 560–563
Stutzman-Engwall K, Conlon S, Fedechko R, Kaczmarek F, McArthur H, Krebber A, Chen Y, Minshull J, Raillard SA, Gustafsson C (2003). Engineering the aveC gene to enhance the ratio of doramectin to its CHC-B2 analogue produced in Streptomyces avermitilis. Biotechnol Bioeng 82: 359–369
del Cardayre SB (2003) Delivering industrial microorganisms through gene, pathway, and genome shuffling. Abstr S75, SIM Ann Mtg Prog & Abstr 73
Vinci VA, Hoerner TD, Coffman AD, Schimmel TG, Dabora RL, Kirpekar AC, Ruby CL, Stieber RW (1991) Mutants of a lovastatin-hyperproducing Aspergillus terreus deficient in the production of sulochrin. J Indust Microbiol 8: 113–120
Pospisil S, Peterkova M, Krumphanzl V, Vanek Z (1984) Regulatory mutants of Streptomyces cinnamonensis producing monensin A. FEMS Microbiol Lett 24: 209–213
Shier WT, Rinehart KL Jr, Gottlieb D (1969) Preparation of four new antibiotics from a mutant of Streptomyces fradiae. Proc Natl Acad Sci USA 63: 198–204
Nagaoka K, Demain AL (1975) Mutational biosynthesis of a new antibiotic, streptomutin A, by an idiotroph of Streptomyces griseus. J Antibiot 28: 627–635
Lemke JR, Demain AL (1976) Preliminary studies on streptomutin A. Eur J Appl Microbiol 2: 91–94
Daum SJ, Lemke JR (1979) Mutational biosynthesis of new antibiotics. Ann Rev Microbiol 33: 241–265
Kitamura S, Kase H, Odakura Y, Iida T, Shirahata K, Nakayama K (1982) 2-Hydroxysagamicin: A new antibiotic produced by mutational biosynthesis of Micromonospora sagamiensis. J Antibiot 35: 94–97
Cropp TA, Wilson DJ, Reynolds KA (2000) Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin. Nature Biotechnol 18: 980–983
McGuire J, Thomas MC, Pandey RC, Toussaint M, White RJ (1981) Biosynthesis of daunorubicin glycosides: analysis with blocked mutants. In: M Moo-Young (ed): Advances in biotechnology. Vol. III. Fermentation products. Pergammon Press, New York, 117–122
Cassinelli G, Di Matteo F, Forenza S, Ripamonti M, Rivola G, Arcamone F, Di Marco A, Cassaza AM, Soranzo C, Pratesi G (1980) New anthracycline glycosides from Micromonospora. II. Isolation, characterization and biological properties. J Antibiot 33: 1468–1473
Yoshimoto A, Matsuzawa Y, Matsuhashi Y, Oki T, Takeuchi T, Umezawa H (1981) Trisarubicinol, new antitumor anthracycline antibiotic. J Antibiot 34: 1492–1494
Kirst HA, Wild GM, Baltz RH, Seno ET, Hamill RL, Paschal JW, Dorman DE (1983) Elucidation of structure of novel macrolide antibiotics produced by mutant strains of Streptomyces fradiae. J Antibiot 36: 376–382
Spagnoli R, Cappalletti L, Toscano L (1983) Biological conversion of erythronolide B, an intermediate of erythromycin biogenesis, into new ‘hybrid’ macrolide antibiotics. J Antibiot 36: 365–375
Lee BK, Puar MS, Patel M, Bartner P, Lotvin J, Munayyer H, Waitz JA (1983) Multistep bioconversion of 20-deoxo-20-dihydro-12, 13-deepoxy-12,13-dehydrorosaranolide to 22-hydroxy-23-o-mycinosyl-20-deoxo-20-dihydro-12,13-deepoxy-rosaramicin. J Antibiot 36: 742–743
McCormick JRD (1965) Biosynthesis of the tetracyclines. In: Z Vanek, Z Hostalek (eds): Biogenesis of antibiotic substances. Publishing House of the Czechoslovak Academy of Science, Prague, 73–91
Kominek LA (1972) Biosynthesis of novobiocin by Streptomyces niveus. Antimicrob Agents Chemother 1: 123–134
Martin JR, Perun TJ, Girolami RL (1966) Studies on the biosynthesis of erythromycins. I. Isolation of an intermediate glycoside, 3-alpha-L-mycarosylerythronolide B. Biochemistry 5: 2852–2856
Martin JR, Rosenbrook WR (1967) Studies on the biosynthesis of erythromycins. II. Isolation and structure of a biosynthetic intermediate, 6-deoxyerythronolide B. Biochemistry 6: 435–440
Pearce CJ, Akhtar M, Barnett JEG, Mercier D, Sepulchre AM, Gero S (1978) Sub-unit assembly in the biosynthesis of neomycin. The synthesis of 5-O-β-D-ribofuranosyl and 4-O-β-D-ribofuranosyl-2,6-dideoxystreptamines. J Antibiot 31: 74–81
Baltz RH, Seno ET, Stonesifer J, Wild GM (1983) Biosynthesis of the macrolide antibiotic tylosin: a preferred pathway from tylactone to tylosin. J Antibiot 36: 131–141
Takeda K, Aihara K, Furumai T, Ito Y (1978) An approach to the biosynthetic pathway of butirosins and the related antibiotics. J Antibiot 31: 250–253
Fujiwara T, Takahashi Y, Matsumoto K, Kondo E (1980) Isolation of an intermediate of 2-deoxystreptamine biosynthesis from a mutant of Bacillus circulans. J Antibiot 33: 824–829
Kase H, Odakura Y, Nakayama K (1982) Sagamycin and the related aminoglycosider: fermentation and biosynthesis. I. Biosynthetic studies with the blocked mutants of Micromonospora sagamiensis. J Antibiot 35: 1–9
Hanssen R, Kirby R (1983) The induction by N-methyl-N’-nitro-nitrosoguanidine of multiple closely linked mutations in Streptomyces bikiniensis ISP5235 affecting streptomycin resistance and streptomycin biosynthesis. FEMS Microbiol Lett 17: 317–320
Penzikova GA, Levitov MM (1970) A study on transamidinase activity with respect to streptomycin biosynthesis. Biologiya 39: 337–342
Vaughn RV, Lotvin J, Puar MS, Patel M, Kershner A, Kalyanpur MG, Marquez J, Waitz JA (1982) Isolation and characterization of two 16-membered lactones: 20-deoxorosaramicin and 20-deoxo-12,13-desepoxy-12,13-dehydrorosaramicin aglycones, from a mutant strain of Micromonospora rosaria. J Antibiot 35: 251–253
Motamedi H, Wendt-Pientowski E, Hutchinson CR (1986) Isolation of tetracenomycin C non-producing Streptomyces glaucescens mutants. J Bacteriol 167: 575–580
Yue S, Motamedi H, Wendt-Pienskowski E, Hutchinson CR (1986) Anthracycline metabolites of tetracenomycin-non-producing Streptomyces glaucescens. J Bacteriol 167: 581–586
Troost T, Katz E (1979) Phenoxazinone biosynthesis: accumulation of a precursor, 4-methyl-3-hydroxyanthranilic acid, by mutants of Streptomyces parvulus. J Gen Microbiol 1: 121–132
Nozaki Y, Kitano K, Imada I (1984) Blocked mutants in the biosynthesis of carbapenem antibiotics from Streptomyces griseus subsp. cryophilus. AgricBiol Chem 48: 37–44
Kojima I, Fukagawa Y, Okabe M, Ishikura T, Shibamoto N (1988) Mutagenesis of OA-6129 carbapenem-producing blocked mutants and the biosynthesis of carbapenems. J Antibiot 41: 899–907
Kibby JJ, McDonald IA, Rickards RW (1980) 3-Amino-5-hydroxybenzoic acid as a key intermediate in ansamycin and maytansinoid biosynthesis. J Chem Soc Chem Comm 768–769
Ghisalba O, Fuhrer H, Richter W, Moss S (1981) A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain. J Antibiot 34: 58–63
Gaucher GM, Lam KS, Grootwassink JWD, Neway J, Deo YM (1981) The initiation and longevity of patulin biosynthesis. Devel Indust Microbiol 22: 219–232
Byng GS, Eustice DC, Jensen RA (1979) Biosynthesis of phenazine pigments in mutant and wild-type cultures of Pseudomonas aeruginosa. J Bacteriol 138: 846–852
Jarai M (1961) Genetic recombination in Streptomyces aureofaciens. Acta Microbiol Acad Sci Hung 8: 73–79
Mindlin SZ (1969) Genetic recombination in the actinomycete breeding. In: G Sermonti, M Alacevic (eds): Genetics and breeding of Streptomyces. Yugoslav Academy of Sciences and Arts, Zagreb, 147–159
Kieser HM, Kieser T, Hopwood DA (1992) A combined genetic and physical map of the Streptomyces coelicolor A3(2) chromosome. J Bacteriol 174: 5496–5507
Ryu DDY, Kim KS, Cho NY, Pai HS (1983) Genetic recombination in Micromonospora rosaria by protoplast fusion. Appl Environ Microbiol 45: 1854–1858
Choi KP, Kim KH, Kim JW (1997) Strain improvement of clavulanic acid producing Streptomyces clavuligerus. Abstr. 12P9, 10th Internat Symp Biol Actinomycetes (Beijing)
Hamlyn PF, Ball C (1979) Recombination studies with Cephalosporium acremonium. In: OK Sebek, AI Laskin (eds): Genetics of industrial microorganisms. ASM, Washington, DC, 185–191
Lein J (1986) The Panlabs penicillin strain improvement program. In: Z Vanek, Z Hostalek (eds): Overproduction ofmicrobial metabolites; strain improvement and process control strategies. Butterworth Publishers, Boston, 105–139
Wesseling AC, Lago B (1981) Strain improvement by genetic recombination of cephamycin producers, Nocardia lactamdurans and Streptomyces griseus. Devel Indust Microbiol 22: 641–651
Yamashita F, Hotta K, Kurasawa S, Okami Y, Umezawa H (1982) Antibiotic formation by interspecific protoplast fusion in streptomycetes and emergence of drug resistance by protoplast regeneration. Abstr P-II-20, 4th Internatl Symp Genet Indust Microorgs, (Kyoto): 108
Traxler P, Schupp T, Wehrli W (1982) 16,17-dihydrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S, two novel rifamycins from a recombinant strain C5/42 of Nocardia mediterranei. J Antibiot 35: 594–601
Hopwood DA (1983) Actinomycete genetics and antibiotic production. In: LC Vining (ed): Biochemistry and genetic regulation of commercially important antibiotics. Addison Wesley, Reading, MA, 1–23
Okanishi M, Suzuki N, Furuta T (1996) Variety of hybrid characters among recombinants obtained by interspecific protoplast fusion in streptomycetes. Biosci Biotechnol Biochem 60:1233–1238
Hershberger CL (1996) Metabolic engineering of polyketide biosynthesis. Curr Opin Biotechnol 7: 560–562
Gomi S, Ikeda D, Nakamura H, Naganawa H, Yamashita F, Hotta K, Kondo S, Okami Y, Umezawa H, Iitaka Y (1984) Isolation and structure of a new antibiotic, indolizomycin, produced by a strain SK2-52 obtained by interspecies fusion treatment. J Antibiot 37: 1491–1494
Kinashi H, Shimaji M (1987) Detection of giant linear plasmids in antibiotic producing strains of Streptomyces by the OFAGE technique. J Antibiot 40: 913–916
Binnie C, Warren M, Butler MJ (1989) Cloning and heterologous expression in Streptomyces lividans of Streptomyces rimosus genes involved in oxytetracycline biosynthesis. J Bacteriol 171: 887–895
Butler MJ, Friend EJ, Hunter IS, Kaczmarek FS, Sugden DA, Warren M (1989) Molecular cloning of resistance genes and architecture of a linked gene cluster involved in biosynthesis of oxytetracycline by Streptomyces rimosus. Molec Gen Genet 215: 231–238
Arisawa A, Kawamura N, Narita T, Kojima I, Okamura K, Tsunekawa H, Yoshioka T, Okamoto R (1996) Direct fermentative production of acyltylosins by genetically-engineered strains of Streptomyces fradiae. J Antibiot 49: 349–354
McDougall S, Neilands JB (1984) Plasmid-and chromosome-coded aerobactin synthesis in enteric bacteria: insertion sequences flank operon in plasmid-mediated systems. J Bacteriol 159: 300–305
Roberts M, Leavitt RW, Carbonetti NH, Ford S, Cooper RA, Williams PH (1986) RNA-DNA hybridization analysis of transcription of the plasmid ColV-K30 aerobactin gene cluster. J Bacteriol 167: 467–472
Moon YH, Tanabe T, Funahashi T, Shiuchi K, Nakao H, Yamamoto S (2004) Identification and characterization of two contiguous operons required for aerobactin transport and biosynthesis in Vibrio mimicus. Microbiol Immunol 48: 389–398
Perez-Diaz JC, Clowes RC (1980) Physical characterization of plasmids determining synthesis of a microcin which inhibits methionine synthesis in Escherichia coli. J Bacteriol 141:1015–1023
Crameri R, Davies JE, Huetter R (1986) Plasmid curing and generation of mutations induced with ethidium bromide in Streptomycetes. J Gen Microbiol 132: 819–824
Berg DE, Berg CM (1983) The prokaryotic transposable element Tn5. Bio/Technology 1: 417–435
McHenney MA, Baltz RH (1996) Gene transfer and transposition mutagenesis in Streptomyces roseosporus: mapping of insertions that influence daptomycin or pigment production. Microbiology 142: 2363–2373
Baltz RH, McHenney MA, Cantwell CA, Queener SW, Solenberg PJ (1997) Applications of transposition mutagenesis in antibiotic producing streptomyces. Ant v Leeuwenhoek 71:179–187
Solenberg PJ, Cantwell CA, Tietz AJ, McGilvray D, Queener SW, Baltz RH (1996) Transposition mutagenesis in Streptomyces fradiae: identification of a neutral site for the stable insertion of DNA by transposon exchange. Gene 16: 67–72
Ikeda H, Takada Y, Pang CH, Tanaka H, Omura S (1993) Transposon mutagenesis by Tn4560 and applications with avermectin-producing Streptomyces avermitilis. J Bacteriol 175: 2077–2082
Thompson CJ, Ward JM, Hopwood DH (1982) Cloning of antibiotic resistance and nutritional genes in streptomycetes. J Bacteriol 151: 668–677
Baltz RH, Hosted TJ (1996) Molecular genetic methods for improving secondary-metabolite production in actinomycetes. Trends Biotechnol 14: 245–250
Martin JF, Gil JA (l984) Cloning and expression of antibiotic production genes. Bio/Technology 2: 63–72
Liras P (1988) Cloning of antibiotic biosynthetic genes. In: JA Thompson (ed): Use of recombinant DNA techniques for improvement of fermentation organisms. CRC Press, Boca Raton, 217–253
Coco EA, Narva KE, Feitelson JS (1991) New classes of Streptomyces coelicolor A3(2) mutants blocked in undecylprodigiosin (Red) biosynthesis. Mol Gen Genet 227: 28–32
Chen CW, Lin HF, Kuo CL, Tsai HL, Tsai JFY (1988) Cloning and expression of a DNA sequence conferring cephamycin C production. Bio/Technology 6: 1222–1224
Demain AL, Elander RP (1999) The β-lactam antibiotics: past, present, and future. Ant v Leeuwenhoek 75: 5–19
Diez B, Gutierrez S, Barredo JL, van Solinger P, van der Voort LHM, Martin JF (1990) The cluster of penicillin biosynthetic genes. Identification and characterization of the pcbAB gene encoding the γ-aminoadipyl-cysteinyl-valine synthetase and linkage to the pcbC and pcbDE genes. J Biol Chem 265: 16358–16365
Gutierrez S, Diez B, Alvarez E, Barredo JL, Martin JF (1991) Expression of the penDE gene of Penicillium chrysogenum encoding isopenicillin N acyltransferase in Cephalosporium acremonium: production of benzyl penicillin by the transformants. Mol Gen Genet 225: 56–64
Carr LG, Skatrud PL, Sheetz ME, Queener SW, Ingolia TD (1986) Cloning and expression of the isopenicillin N synthetase gene from Penicillium chrysogenum. Gene 48: 257–266
Weigel BJ, Burgett SG, Chen VJ, Skatrud PL, Frolik CA, Queener SW, Ingolia TD (1988) Cloning and expression in Escherichia coli of isopenicillin N synthetase genes from Streptomyces lipmanii and Aspergillus nidulans. J Bacteriol 170: 3817–3826
Leskiw BK, Aharonowitz Y, Mevarech M, Wolfe S, Vining LC, Westlake DWS, Jensen SE (1988) Cloning and nucleotide sequence determination of the isopenicillin N synthetase gene from Streptomyces clavuligerus. Gene 62: 187–196
Garcia-Dominguez M, Liras P, Martin JF (1991) Cloning and characterization of the isopenicillin N synthase gene of Streptomyces griseus NRRL 3851 and studies of expression and complementation of the cephamycin pathway in Streptomyces clavuligerus. Antimicrob Agents Chemother 35: 44–52
Shiffman D, Mevarech M, Jensen SE, Cohen G, Aharonowitz Y (1988) Cloning and comparative analysis of the gene encoding isopenicillin N synthase in Streptomyces. Mol Gen Genet 214: 562–569
Skatrud PL, Fisher DL, Ingolia TD, Queener SW (1987) Improved transformation of Cephalosporium acremonium. In: M Alacevic, D Hranueli (eds): Genetics of industrial microorganisms, part B. Pliva, Zagreb, 111–119
Theilgaard HA, van den Berg MA, Mulder CA, Bovenberg RAL, Nielsen J (2001) Quantitative analysis of Penicillium chrysogenum Wis54-1255 transformants overexpressing the penicillin biosynthetic genes. Biotechnol Bioeng 72: 379–388
Skatrud PL, Tietz AJ, Ingolia TD, Cantwell CA, Fisher DL, Chapman JL, Queener SW (1989) Use of recombinant DNA to improve production of cephalosporin C by Cephalosporium acremonium. Bio/Technology 7: 477–485
Rodriguez-Saiz M, Lembo M, Bertetti L, Muraca R, Velasc, J, Malcangi A, Luis de la Fuente J, Barredo JL (2004) Strain improvement for cephalosporin production by Acremonium chrysogenum using geneticin as a suitable transformation marker. FEMS Microbiol Lett 235:43–49
Basch J, Chiang S-JD (1998) Genetic engineering approach to reduce undesirable byproducts in cephalosporin C fermentation. J Indust Microbiol Biotechnol 20: 344–353
Mayer H, Collins J, Wagner F (1980) Cloning of the penicillin G-acylase gene of Escherichia coli ATCC 11105 on multicopy plasmids. In: HH Weetall, GP Royer (eds): Enzyme engineering, vol. 5. Plenum, New York, 61–69
Elander RP (1995) Genetic engineering applications in the development of selected industrial enzymes and therapeutic proteins. In: R Sankaran, KS Manja (eds): Microbes for better living. Defense Food Research Laboratory, Mysore, India, 619–628
Luo H, Yu H, Li Q, Shen Z (2004) Cloning and co-expression of D-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase genes in Escherichia coli. Enzyme Microb Technol 35: 514–580
Stephanopoulos G (1999) Metabolic fluxes and metabolic engineering. Metab Eng 1: 1–11
Nielsen J (2001) Metabolic engineering. Appl Microbiol Biotechnol 55: 263–283
Kacser H, Acerenza L (1993) A universal method for achieving increases in metabolite production. Eur J Biochem 216: 361–367
Khetan A, Hu WS (1999) Metabolic engineering of antibiotic biosynthetic pathways. In: AL Demain, JE Davies (eds): Manual of industrial microbiology and biotechnology. ASM Press, Washington, DC, 717–724
Khetan A, Hu W-S (1999) Metabolic engineering of antibiotic biosynthesis for process improvement. In: SY Lee, ET Papoutsakis (eds): Metabolic engineering. Marcel Dekker, New York, 177–202
Thykaer J, Nielsen J (2003) Metabolic engineering of β-lactam production. Metab Eng 5: 56–69
Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C (2001) Biosynthesis of complex polyketides in a metabolically engineered strain of Escherichia coli. Science 291: 1790–1792
Khosla C, Keasling JD (2003) Metabolic engineering for drug discovery and development. Nature Rev/Drug Disc 2: 1019–1025
Otten SL, Stutzman-Engwall J, Hutchinson CR (1990) Cloning and expression of daunorubicin biosynthesis genes from Streptomyces peucetius and S. peucetius subsp. caisius. J Bacteriol 172: 3427–3434
Decker H, Summers RG, Hutchinson CR (1994) Overproduction of the acyl carrier protein component of a type II polyketide synthase stimulates production of tetracenomycin biosynthetic intermediates in Streptomyces glaucescens. J Antibiot 47: 54–63
Madduri K, Waldron C, Matsushima P, Broughton MC, Crawford K, Merlo DJ, Baltz RH (2001) Genes for the biosynthesis of spinosyns: applications for yield improvement in Saccharopolyspora spinosa. J Indust Microbiol Biotechnol 27: 399–402
Butler MJ, Bruheim P, Jovetic S, Marinelli F, Postma PW, Bibb MJ (2002) Engineering of primary carbon metabolism for improved antibiotic production in Streptomyces lividans. Appl Environ Microbiol 68: 4731–4739
Voegtli M, Chang PC, Cohen SN (1994) afsR2: a previously undetected gene encoding a 63-amino acid protein that stimulates antibiotic production in Streptomyces lividans. Mol Microbiol 14: 643–653
Lee JY, Hwang YS, Kim SS, Kim ES, Choi CY (2000) Effect of a global regulatory gene, afsR2, from Streptomyces lividans on avermectin production in Streptomyces avermitilis. J Biosci Bioeng 89: 606–608
Hwang YS, Kim ES, Biro S, Choi CY (2003) Cloning and analysis of a DNA fragment stimulating avermectin production in various Streptomyces avermitilis strains. Appl Environ Microbiol 69: 1263–1269
Geistlich M, Losick R, Turner JR, Rao RN (1992) Characterization of a novel regulatory gene governing the expression of a polyketide synthase gene in Streptomyces ambofaciens. MolMicrobiol 6: 2019–2029
Lombo F, Brana AF, Mendez C, Salas JA (1999) The mithramycin gene cluster of Streptomyces argillaceus contains a positive regulatory gene and two repeated DNA sequences that are located at both ends of the cluster. J Bacteriol 181: 642–647
Kennedy J, Auclair K, Kendrew SG, Park C, Vederas JC, Hutchinson CR (1999) Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis. Science 284: 1368–1372
Mao Y, Varoglu M, Sherman DH (1999) Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564. Chem Biol 6: 251–263
Brian P, Riggle PJ, Santos RA, Champness WC (1996) Global negative regulation of Streptomyces coelicolor antibiotic synthesis mediated by an absA-encoded putative transduction system. J Bacteriol 178: 3221–3231
Volokhan O, Skletta H, Sekurova ON, Ellingsen TE, Zotchev SB (2005) An unexpected role for the putative 4′-phosphopantetheinyl transferase-encoding gene nysF in the regulation of nystatin biosynthesis in Streptomyces noursei ATCC 11455. FEMS Microbiol Lett 249: 57–64
Cox KL, Fishman SE, Larson JL, Stanzak R, Reynolds PA, Yeh WK, Van Frank RM, Birmingham VA, Hershberger CL, Seno ET (1987) Cloning and characterization of genes involved in tylosin biosynthesis. In: M Alacevic, D Hranueli, Z Toman (eds): Genetics of industrial microorganisms, part B. Pliva, Zagreb, 337–346
Fishman SE, Cox K, Larson JL, Reynolds PA, Seno ET, Yeh WK, Van Frank R, Hershberger CL (1987) Cloning genes for the biosynthesis of a macrolide antibiotic. Proc Natl Acad Sci USA 84: 8248–8252
Kennedy J, Turner G (1996) δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine synthetase is a rate limiting enzyme for penicillin production in Aspergillus nidulans. Mol Gen Genet 253: 189–197
Matsuda A, Sugiura H, Matsuyama K, Matsumoto H, Ichikawa S, Komatsu KI (1992) Molecular cloning of acetyl coenzyme A: deacetylcephalosporin C O-acetyltransferase cDNA from Acremonium chrysogenum: sequence and expression of catalytic activity in yeast. Biochem Biophys Res Commun 182: 995–1001
Mathison L, Soliday C, Stepan T, Aldrich T, Rambosek J (1993) Cloning, characterization, and use in strain improvement of the Cephalosporium acremonium gene cefG encoding acetyl transferase. Curr Genet 23: 33–41
Gutierrez S, Velasco J, Marcos AT, Fernandez FJ, Fierro F, Barredo JL, Diez B, Martin JF (1997) Expression of the cefG gene is limiting for cephalosporin biosynthesis in Acremonium chrysogenum. Appl Microbiol Biotechnol 48: 606–614
Cantwell C, Beckmann R, Whiteman P, Queener SW, Abraham EP (1992) Isolation of deacetoxycephalosporin C from fermentation broths of Penicillium chrysogenum transformants: construction of a new fungal biosynthetic pathway. Proc R Soc Lond (Biol) 248: 283–289
Crawford L, Stepan AM, Mcada PC, Rambosek JA, Conder MJ, Vinci VA, Reeves CD (1995) Production of cephalosporin intermediates by feeding adipic acid to recombinant Penicillium chrysogenum strains expressing ring expansion activity. Bio/Technology 13: 58–62
Velasco J, Adrio JL, Moreno MA, Diez B, Soler G, Barredo JL (2000) Environmentally safe production of 7-aminodeacetoxycephalosporanic acid (7-ADCA) using recombinant strains of Acremonium chrysogenum. Nature Biotechnol 18: 857–861
Brunker P, Minas W, Kallio PT, Bailey JE (1998). Genetic engineering of an industrial strain of Saccharopolyspora erythrea for stable expression of the Vitreoscilla hemoglobin gene (vhb). Microbiology 144: 2441–2448
Minas W, Brunker P, Kallio PT, Bailey JE (1998) Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol Prog 1: 561–566
Lombo F, Pfeifer B, Leaf T, Ou S, Kim YS, Cane DE, Licari P, Khosla C (2001) Enhancing the atom economy of polyketide biosynthetic processes through metabolic engineering. Biotechnol Prog 17: 612–617
Bailey JE, Sburlati A, Hatzimanikatis V, Lee K, Renner WA, Tsai PS (1996) Inverse metabolic engineering: a strategy for directed genetic engineering of useful phenotypes. Biotechnol Bioeng 52: 109–121
Khosla C, Bailey JE (1988) Heterologous expression of a bacterial haemoglobin improves the growth properties of recombinant Escherichia coli. Nature 331: 633–635
Bro C, Nielsen J (2004) Impact of ‘ome’ analyses on inverse metabolic engineering. Metab Eng 6: 204–211
Reeves AR, Cernota WH, Brikun IA, Wesley RK, Weber JM(2004) Engineering precursor flow for increased erythromycin production in Aeromicrobium erythreum. Metab Eng 6: 300–312
Ohnishi J, Mitsuhashi S, Hayashi M, Ando S, Yokoi H, Ochiai K, Ikeda M (2002) A novel methodology employing Corynebacterium glutamicum genome information to generate a new L-lysine-producing mutant. Appl Microbiol Biotechnol 58: 217–223
Stephanopoulos G, Alper H, Moxley J (2004) Exploiting biological complexity for strain improvement through systems biology. Nature Biotechnol 22: 1261–1267
Askenazi M, Driggers EM, Holtzman DA, Norman TC, Iverson S, Zimmer DP, Boers ME, Blomquist PR, Martinez EJ, Monreal AW et al (2003) Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nature Biotechnol 21: 150–156
Lum AM, Huang J, Hutchinson CR, Kao CM (2004) Reverse engineering of industrial pharmaceutical-producing actinomycete strains using DNA microarrays. Metab Eng 6: 186–196
Skandalis A, Encell LP, Loeb LA (1997) Creating novel enzymes by applied molecular evolution. Chem Biol 4: 889–898
Kuchner O, Arnold FH (1997) Directed evolution of enzyme catalysis. Trends Biotechnol 15: 523–530
Arnold FH (1998) Design by directed evolution. Acc Chem Res 31: 125–131
Arnold FH (2001) Combinatorial and computational challenges for biocatalyst design. Nature 409: 253–257
Zhao H, Chockalingam K, Chen Z (2002) Directed evolution of enzymes and pathways for industrial biocatalysis. Curr Opin Biotechnol 13: 104–110
Ness JE, Del Cardayre SB, Minshull J, Stemmer WP (2000) Molecular breeding: the natural approach to protein design. Adv Prot Chem 55: 261–292
Stemmer WP (1994) Rapid evolution of a protein in vitro by DNA shuffling. Nature 370: 389–391
Zhao H, Arnold FH (1997) Optimization of DNA shuffling for high fidelity recombination. Nucleic Acids Res 25: 1307–1308
Patten PA, Howard RJ, Stemmer W (1997) Applications of DNA shuffling to pharmaceuticals and vaccines. Curr Opin Biotechnol 8: 724–733
Kurtzman AL, Govindarajan S, Vahle K, Jones JT, Heinrichs V, Patten PA (2001) Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins. Curr Opin Biotechnol 12: 361–370
Lutz S, Ostermeier M, Moore GL, Maranas CD, Benkovic SP (2001) Creating multiplecrossover DNA libraries independent of sequence identity. Proc Natl Acad Sci USA 98: 11248–11253
Marshall SH (2002) DNA shuffling: induced molecular breeding to produce new generation long-lasting vaccines. Biotechnol Adv 20: 229–238
Locher CP, Soong NW, Whalen RG, Punnonen J (2004) Development of novel vaccines using DNA shuffling and screening strategies. Curr Opin Mol Ther 6: 34–39
Zhang YX, Perry K, Vinci VA, Powell K, Stemmer WPC, del Cardayre SB (2002) Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature 415: 644–646
Hutchinson C (1998) Combinatorial biosynthesis for new drug discovery. Curr Opin Microbiol 1: 319–329
Reeves CD (2003) The enzymology of combinatorial biosynthesis. Crit Rev Biotechnol 23: 95–147
Hopwood DA, Malpartida F, Kieser HM, Ikeda H, Duncan J, Fujii I, Rudd BAM, Floss, HG, Omura S (1985) Production of ‘hybrid’ antibiotics by genetic engineering. Nature 314: 642–644
Rodriguez E, McDaniel R (2001) Combinatorial biosynthesis of antimicrobials and other natural products. Curr Opin Microbiol 4: 526–534
Donadio S, Sosio M (2003) Strategies for combinatorial biosynthesis with modular polyketide synthases. Comb Chem High Throughput Screen 6: 489–500
Kantola J, Kunnari T, Mantsala P, Ylihonko K (2003) Expanding the scope of aromatic polyketides by combinatorial biosynthesis. Comb Chem High Throughput Screen 6: 501–512
McAlpine JB, Tuan JS, Brown DP, Grebner KB, Whittern DN, Buko A, Katz L (1987) New antibiotics from genetically engineered actinomycetes. I.2-Norerythromycins, isolation and structural determinations. J Antibiot 40: 1115–1122
Epp JK, Huber MLB, Turner JR, Goodson T, Schoner BE (1989) Production of hybrid macrolide antibiotic in Streptomyces ambofaciens and Streptomyces lividans by introduction of a cloned carbomycin biosynthetic gene from Streptomyces thermotolerans. Gene 85: 293–301
Weber JM, Leung JO, Swanson SJ, Idler KB, McAlpine JB (1991) An erythromycin derivative produced by targeted gene disruption in Saccharopolyspora erythraea. Science 252: 114–117
Donadio S, Staver MJ. McAlpine JB, Swanson SJ, Katz L (1991) Modular organization of genes required for complex polyketide biosynthesis. Science 252: 675–679
Donadio S, McAlpine JB, Sheldon PA, Jackson MA, Katz L (1993) An erythromycin analog produced by reprogramming of polyketide synthesis. Proc Natl Acad Sci USA 90: 7119–7123
Hara O, Hutchinson CR (1992) A macrolide 3-O-acyltransferase gene from the midecamycin-producing species Streptomyces mycarofaciens. J Bacteriol 174: 5141–5144
Katz L, Donadio S (1993) Polyketide synthesis: prospects for hybrid antibiotics. Annu Rev Microbiol 47: 875–912
Hopwood DA (1993) Genetic engineering of Streptomyces to create hybrid antibiotics. Curr Opin Biotechnol 4: 531–537
McDaniel R, Ebert-Khosla S, Hopwood D, Khosla C (1993) Engineered biosynthesis of novel polyketides. Science 262: 1546–1550
McDaniel R, Ebert-Khosla S, Hopwood D, Khosla C (1993) Engineered biosynthesis of novel polyketides: manipulation and analysis of an aromatic polyketide synthase with unproven catalytic specificities. J Am Chem Soc 115: 11671–11675
McDaniel R, Thamchaipenet A, Gustafsson C, Fu H, Betlach M, Betlach M, Ashley G (1999) Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel ‘unnatural’ natural products. Proc Natl Acad Sci USA 96: 1846–1851
Khosla C, McDaniel R, Ebert-Khosla S, Torres R. Sherman DH, Bibb MJ, Hopwood DA (1993) Genetic construction and functional analysis of hybrid polyketide synthases containing heterologous acyl carrier proteins. J Bacteriol 175: 2197–2204
Decker H, Hutchinson CR (1993) Transcriptional analysis of the Streptomyces glaucescens tetracenomycin biosynthesis gene cluster. J Bacteriol 175: 3887–3892
Hutchinson CR, Fujii I (1995) Polyketide synthase gene manipulation: a structure-function approach in engineering novel antibiotics. Annu Rev Microbiol 49: 201–238
Tsoi CJ, Khosla C (1995) Combinatorial biosynthesis of unnatural natural products — the polyketide example. Chem Biol 2: 355–362
Kao CM, Luo GL, Katz L, Cane DE, Khosla C (1995) Manipulation of macrolide ring size by directed mutagenesis of a modular polyketide synthase. J Am Chem Soc 117: 9105–9106
Pacey MS, Dirlam JP, Geldart RW, Leadlay PF, McArthur HA, McCormick EL, Monday RA, O’Connell TN, Staunton J, Winchester TJ (1998) Novel erythromycins from a recombinant Saccharopolyspora erythraea strain NRRL 2338pIG1. I. Fermentation, isolation and biological activity. J Antibiot 51: 1029–1034
Wohlert SE, Blanco G, Lombo F, Fernandez E, Brana AF, Reich S, Udvarnoki G, Mendez C, Decker H, Frevert J et al (1998) Novel hybrid tetracenomycins through combinatorial biosynthesis using a glycosyltransferase encoded by the elm-genes in cosmid 16F4 and which shows a very broad sugar substrate specificity. J Amer Chem Soc 120: 10596–10601
Xue Q, Hutchinson CR, Santi DV (1999) A multi-plasmid approach to preparing large libraries of polyketides. Proc Natl Acad Sci USA 96: 11740–11745
Pfeifer BA, Khosla C (2001) Biosynthesis of polyketides in heterologous hosts. Microbiol Molec Biol Rev 65: 106–118
Trefzer A, Blanco G, Remsing L, Kunzel E, Rix U, Lipata F, Brana AF, Mendez C, Rohr J, Bechtold A et al (2002) Rationally designed glycosylated premithramycins: hybrid aromatic polyketides using genes fom three different biosynthetic pathways. J AmChem Soc 124: 6056–6062
Zhao L, Ahlert J, Xue Y, Thorson JS, Sherman DH, Liu H-W (1999) Engineering a methymycin/pikromycin-calicheamicin hybrid: construction of two new macrolides carrying a designed sugar moiety. J Am Chem Soc 121: 9881–9882
Mendez C, Salas JA (2001) Altering the glycosylation pattern of bioactive compounds. Trends Biotechnol 19: 449–456
Bartel PL, Zhu CB, Lampel JS, Dosch DC, Connors NC, Strohl WR, Beale JM Jr, Floss HG (1990) Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes; clarification of actinorhodin gene functions. J Bacteriol 172: 4816–4826
Strohl WR, Bartel PL, Li Y, Connors NC, Woodman RH (1991) Expression of polyketide biosynthesis and regulatory genes in heterologous streptomycetes. J Indust Microbiol 7: 163–174
Hwang CK, Kim HS, Hong YS, Kim YH, Hong SK, Kim SJ, Lee JJ (1995) Expresssion of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin. Antimicrob Agents Chemother 39: 1616–1620
Niemi J, Mantsala P (1995) Nucleotide sequences and expression of genes from Streptomyces purpurescens that cause the production of new anthracyclines in Streptomyces galilaeus. J Bacteriol 177: 2942–2945
Ylihonko K, Hakala J, Kunari T, Mantsala P (1996) Production of hybrid anthracycline antibiotics by heterologous expression of Streptomyces nogalaternogalamycin biosynthesis genes. Microbiology 142: 1965–1972
Kim HS, Hong YS, Kim YH, Yoo OJ, Lee JJ (1996) New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133. J Antibiot 49: 355–360
Stachelhaus T, Schneider A, Marahiel MA (1995) Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. Science 269: 69–72
Staunton J (1998) Combinatorial biosynthesis of erythromycin and complex polyketides. Curr Opin Chem Biol 2: 339–345
Hopwood DA (2003) The Streptomyces genome — be prepared! Nature Biotechnol 21: 505–506
Ikeda H, Ishikawa J, Hanamoto A, Shinose K, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Omura S (2003) Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nature Biotechnol 21: 526–531
Zazopoulos E, Huang K, Staffa A, Liu W, Bachmann BO, Nonaka K, Ahlert J, Thorson JS, Shen B, Farnet CM (2003) A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nature Biotechnol 21: 187–190
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag, Basel (Switzerland)
About this chapter
Cite this chapter
Demain, A.L., Adrio, J.L. (2008). Strain improvement for production of pharmaceuticals and other microbial metabolites by fermentation. In: Petersen, F., Amstutz, R. (eds) Natural Compounds as Drugs Volume I. Progress in Drug Research, vol 65. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8117-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8117-2_7
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8098-4
Online ISBN: 978-3-7643-8117-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)